‘Coke and fries’ revisited

Proposals for a pharmacy minor ailment scheme are just a push to increase profits of pharmacists and the pharmaceutical industry, a leading GP believes.

“Unless integrity within the pharmacy industry is improved, minor ailment scheme (MAS) programs will simply be another mechanism to increase drug use in the community,” says Dr Evan Ackermann, chair of the Royal Australian College of General Practitioners National Standing Committee – Quality Care.

Touted as a cheaper solution to managing minor presentations in general practice, MAS programs have been developed and